SEC Comment Letter 0000000000-24-009964 to ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc.
Date: Sept. 3, 2024 · CIK: 0001374339 · Accession: 0000000000-24-009964
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281841
Letter
September 3, 2024 Neil Warma Interim Chief Executive Officer ProMIS Neurosciences Inc. Suite 200, 1920 Yonge Street Toronto, Ontario M4S 3E2 Re:ProMIS Neurosciences Inc. Registration Statement on Form S-3 Filed August 29, 2024 File No. 333-281841 Dear Neil Warma: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Robert E. Puopolo, Esq.
Show Raw Text
September 3, 2024
Neil Warma
Interim Chief Executive Officer
ProMIS Neurosciences Inc.
Suite 200, 1920 Yonge Street
Toronto, Ontario
M4S 3E2
Re:ProMIS Neurosciences Inc.
Registration Statement on Form S-3
Filed August 29, 2024
File No. 333-281841
Dear Neil Warma:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Robert E. Puopolo, Esq.